In a quarterly disclosure filed with the SEC, major investor Robert Olstein of Olstein Capital Management revealed the complete liquidation of his firm's position in CVS Health. The filing, which reflects holdings as of June 30, 2026, showed the sale of all 50,000 shares. It is important to remember that these 13F filings are delayed, so the trades occurred at some point during the second quarter of 2026.
The exit from CVS Health coincides with a significant transition for Olstein Capital Management, as Easterly Asset Management completed its acquisition of Olstein's mutual fund business in late June 2026. During the same period, CVS reported strong second-quarter financial results, raising its full-year guidance. No specific reason for the sale of the CVS stake has been publicly disclosed.